Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Doxycycline | Research article

Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care

Authors: Volker H. Hackert, Nicole H. T. M. Dukers-Muijrers, Christian J. P. A. Hoebe

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

From early 2009, the Dutch region of South Limburg experienced a massive outbreak of Q fever, overlapping with the influenza A(H1N1)pdm09 pandemic during the second half of the year and affecting approximately 2.9% of a 300,000 population. Acute Q fever shares clinical features with other respiratory conditions. Most symptomatic acute infections are characterized by mild symptoms, or an isolated febrile syndrome. Pneumonia was present in a majority of hospitalized patients during the Dutch 2007–2010 Q fever epidemic. Early empiric doxycycline, guided by signs and symptoms and patient history, should not be delayed awaiting laboratory confirmation, as it may shorten disease and prevent progression to focalized persistent Q fever. We assessed signs’ and symptoms’ association with acute Q fever to guide early empiric treatment in primary care patients.

Methods

In response to the outbreak, regional primary care physicians and hospital-based medical specialists tested a total of 1218 subjects for Q fever. Testing activity was bimodal, a first “wave” lasting from March to December 2009, followed by a second “wave” which lasted into 2010 and coincided with peak pandemic influenza activity. We approached all 253 notified acute Q fever cases and a random sample of 457 Q fever negative individuals for signs and symptoms of disease. Using data from 140/229(61.1%) Q fever positive and 194/391(49.6%) Q fever negative respondents from wave 1, we built symptom-based models predictive of Q-fever outcome, validated against subsets of data from wave 1 and wave 2.

Results

Our models had poor to moderate AUC scores (0.68 to 0.72%), with low positive (4.6–8.3%), but high negative predictive values (91.7–99.5%). Male sex, fever, and pneumonia were strong positive predictors, while cough was a strong negative predictor of acute Q fever in these models.

Conclusion

Whereas signs and symptoms of disease do not appear to predict acute Q fever, they may help rule it out in favour of other respiratory conditions, prompting a delayed or non-prescribing approach instead of early empiric doxycycline in primary care patients with non-severe presentations. Signs and symptoms thus may help reduce the overuse of antibiotics in primary care during and following outbreaks of Q fever.
Literature
1.
go back to reference Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, al Dahouk S, Neubauer H, et al. Q fever: Single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis. 2012;55:1591–9. Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, al Dahouk S, Neubauer H, et al. Q fever: Single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis. 2012;55:1591–9.
2.
go back to reference Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115–90. Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30:115–90.
3.
go back to reference Kampschreur LM, Dekker S, JCJP H, Lestrade PJ, NHM R, de Jager-Leclercq MGL, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis. 2012;18:563–70. Kampschreur LM, Dekker S, JCJP H, Lestrade PJ, NHM R, de Jager-Leclercq MGL, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis. 2012;18:563–70.
4.
go back to reference Fenollar F, Fournier P, Carrieri MP, Habib G, Messana T, Raoult D. Risks Factors and Prevention of Q Fever Endocarditis. Clin Infect Dis. 2001;33:312–6. Fenollar F, Fournier P, Carrieri MP, Habib G, Messana T, Raoult D. Risks Factors and Prevention of Q Fever Endocarditis. Clin Infect Dis. 2001;33:312–6.
5.
go back to reference Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis. 2013;57:836–44. Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis. 2013;57:836–44.
6.
go back to reference Lassche S, Schrauwen MMWP, Rietveld A, Wijkmans CJ. General practitioners aware of Q-fever. Infectieziekten Bulletin. 2010;21:45–9. Lassche S, Schrauwen MMWP, Rietveld A, Wijkmans CJ. General practitioners aware of Q-fever. Infectieziekten Bulletin. 2010;21:45–9.
7.
go back to reference van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, et al. Three years of Q fever in the Netherlands: faster diagnosis. Ned Tijdschr Geneeskd. 2010;154:A1845. van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, et al. Three years of Q fever in the Netherlands: faster diagnosis. Ned Tijdschr Geneeskd. 2010;154:A1845.
8.
go back to reference Dijkstra F, Riphagen-Dalhuisen J, Wijers N, Hak E, van der Sande MAB, Morroy G, et al. Antibiotic therapy for acute Q fever in the Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect. 2011;139:1332–41. Dijkstra F, Riphagen-Dalhuisen J, Wijers N, Hak E, van der Sande MAB, Morroy G, et al. Antibiotic therapy for acute Q fever in the Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect. 2011;139:1332–41.
9.
go back to reference Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Internal Med. 2000;160:3243–7. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Internal Med. 2000;160:3243–7.
10.
go back to reference Ohmit SE, Monto AS. Symptomatic Predictors of Influenza Virus Positivity in Children during the Influenza Season. Clin Infect Dis. 2006;43:564–8. Ohmit SE, Monto AS. Symptomatic Predictors of Influenza Virus Positivity in Children during the Influenza Season. Clin Infect Dis. 2006;43:564–8.
11.
go back to reference Njeru J, Henning K, Pletz MW, Heller R, Forstner C, Kariuki S, et al. Febrile patients admitted to remote hospitals in northeastern Kenya: Seroprevalence, risk factors and a clinical prediction tool for Q-fever. BMC Infect Dis. 2016;16:244. Njeru J, Henning K, Pletz MW, Heller R, Forstner C, Kariuki S, et al. Febrile patients admitted to remote hospitals in northeastern Kenya: Seroprevalence, risk factors and a clinical prediction tool for Q-fever. BMC Infect Dis. 2016;16:244.
12.
go back to reference Epelboin L, Chesnais C, Boullé C, Drogoul AS, Raoult D, Djossou F, et al. Q fever pneumonia in French Guiana: prevalence, risk factors, and prognostic score. Clin Infect Dis. 2012;55:67–74. Epelboin L, Chesnais C, Boullé C, Drogoul AS, Raoult D, Djossou F, et al. Q fever pneumonia in French Guiana: prevalence, risk factors, and prognostic score. Clin Infect Dis. 2012;55:67–74.
13.
go back to reference Keijmel SP, Krijger E, Delsing CE, Sprong T, Nabuurs-Franssen MH, Bleeker-Rovers CP. Differentiation of acute Q fever from other infections in patients presenting to hospitals, the Netherlands. Emerg Infect Dis. 2015;21:1348–56. Keijmel SP, Krijger E, Delsing CE, Sprong T, Nabuurs-Franssen MH, Bleeker-Rovers CP. Differentiation of acute Q fever from other infections in patients presenting to hospitals, the Netherlands. Emerg Infect Dis. 2015;21:1348–56.
14.
go back to reference Jager MM, Weers-Pothoff G, Hermans MHA, JCE M, JJA S, NHM R, et al. Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol. 2011;18:963–8. Jager MM, Weers-Pothoff G, Hermans MHA, JCE M, JJA S, NHM R, et al. Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol. 2011;18:963–8.
15.
go back to reference Schneeberger PM, Hermans MHA, van Hannen EJ, Schellekens JJA, Leenders ACAP, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol. 2010;17:286–90. Schneeberger PM, Hermans MHA, van Hannen EJ, Schellekens JJA, Leenders ACAP, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol. 2010;17:286–90.
16.
go back to reference Tilburg JJHC, Melchers WJG, Pettersson AM, JWA R, MHA H, van Hannen EJ, et al. Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum. J Clin Microbiol. 2010;11:3923–7. Tilburg JJHC, Melchers WJG, Pettersson AM, JWA R, MHA H, van Hannen EJ, et al. Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum. J Clin Microbiol. 2010;11:3923–7.
17.
go back to reference Hackert VH, Dukers-Muijrers NHTM, van Loo IHM, Wegdam-Blans M, Somers C, Hoebe CJPA. Coxiella burnetii infection is lower in children than in adults after community exposure: overlooked cause of infrequent Q fever reporting in the young. Pediatr Infect Dis J. 2015;34:1283–8. Hackert VH, Dukers-Muijrers NHTM, van Loo IHM, Wegdam-Blans M, Somers C, Hoebe CJPA. Coxiella burnetii infection is lower in children than in adults after community exposure: overlooked cause of infrequent Q fever reporting in the young. Pediatr Infect Dis J. 2015;34:1283–8.
18.
go back to reference Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis. 2002;2:686–91. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis. 2002;2:686–91.
19.
go back to reference Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.
20.
go back to reference Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
21.
go back to reference Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–43. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–43.
22.
go back to reference Schimmer B, ter Schegget R, Wegdam M, Züchner L, de Bruin A, Schneeberger PM, et al. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010;10:69. Schimmer B, ter Schegget R, Wegdam M, Züchner L, de Bruin A, Schneeberger PM, et al. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010;10:69.
23.
go back to reference Jones BF, Stewart MA. Duration of cough in acute upper respiratory tract infections. Aust Fam Phys. 2002;31:971–3. Jones BF, Stewart MA. Duration of cough in acute upper respiratory tract infections. Aust Fam Phys. 2002;31:971–3.
24.
go back to reference Minodier L, Charrel RN, Ceccaldi PE, van der Werf S, Blanchon T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12:215. Minodier L, Charrel RN, Ceccaldi PE, van der Werf S, Blanchon T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12:215.
25.
go back to reference Bruyndonckx R, Stuart B, Little P, Hens N, Ieven M, Butler CC, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology. Clin Microbiol Infect. 2018;24:871–6. Bruyndonckx R, Stuart B, Little P, Hens N, Ieven M, Butler CC, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology. Clin Microbiol Infect. 2018;24:871–6.
26.
go back to reference Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis. 2013;13:123–9. Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis. 2013;13:123–9.
27.
go back to reference Havers FP, Hicks LA, Chung JR, Gaglani M, Murthy K, Zimmerman RK, et al. Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. JAMA Network Open. 2018;1:e180243. Havers FP, Hicks LA, Chung JR, Gaglani M, Murthy K, Zimmerman RK, et al. Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. JAMA Network Open. 2018;1:e180243.
28.
go back to reference Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64 Suppl 3:iii1–55. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64 Suppl 3:iii1–55.
29.
go back to reference Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respiratory Critical Care Med. 2019;200:e45–e67. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respiratory Critical Care Med. 2019;200:e45–e67.
30.
go back to reference Chou CC, Shen CF, Chen SJ, Chen HM, Wang YC, Chang WS, et al. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect. 2019;52:172–99. Chou CC, Shen CF, Chen SJ, Chen HM, Wang YC, Chang WS, et al. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect. 2019;52:172–99.
31.
go back to reference Lim WS, Smith DL, Wise MP, Welham SA. British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015;70:698–700. Lim WS, Smith DL, Wise MP, Welham SA. British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015;70:698–700.
32.
go back to reference Marshall H. NICE guidelines to family doctors on diagnosis of pneumonia. Lancet Respir Med. 2015;3:17. Marshall H. NICE guidelines to family doctors on diagnosis of pneumonia. Lancet Respir Med. 2015;3:17.
33.
go back to reference Million M, Thuny F, Bardin N, Angelakis E, Edouard S, Bessis S, et al. Antiphospholipid Antibody Syndrome with Valvular Vegetations in Acute Q Fever. Clin Infect Dis. 2016;62:537–44. Million M, Thuny F, Bardin N, Angelakis E, Edouard S, Bessis S, et al. Antiphospholipid Antibody Syndrome with Valvular Vegetations in Acute Q Fever. Clin Infect Dis. 2016;62:537–44.
34.
go back to reference Karcic E, Aljicevic M, Bektas S, Karcic B. Antimicrobial Susceptibility/Resistance of Streptococcus pneumoniae. Materia Socio Medica. 2015;27:180–4. Karcic E, Aljicevic M, Bektas S, Karcic B. Antimicrobial Susceptibility/Resistance of Streptococcus pneumoniae. Materia Socio Medica. 2015;27:180–4.
35.
go back to reference Yahiaoui RY, Bootsma HJ, den Heijer CDJ, Pluister GN, John Paget W, Spreeuwenberg P, et al. Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries. BMC Infect Dis. 2018;18:440. Yahiaoui RY, Bootsma HJ, den Heijer CDJ, Pluister GN, John Paget W, Spreeuwenberg P, et al. Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries. BMC Infect Dis. 2018;18:440.
36.
go back to reference Moffa M, Brook I. Tetracyclines, Glycylcyclines, and chloramphenicol. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 2014. p. 322–38. Moffa M, Brook I. Tetracyclines, Glycylcyclines, and chloramphenicol. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 2014. p. 322–38.
37.
go back to reference Eisen DP. Doxycycline. In: Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. 2017. p. 1204–29. Eisen DP. Doxycycline. In: Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. 2017. p. 1204–29.
38.
go back to reference Melenotte C, Protopopescu C, Million M, Edouard S, Carrieri MP, Eldin C, et al. Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever. JAMA Network Open. 2018;1:e181580. Melenotte C, Protopopescu C, Million M, Edouard S, Carrieri MP, Eldin C, et al. Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever. JAMA Network Open. 2018;1:e181580.
39.
go back to reference Wegdam-Blans MCA, Wielders CCH, Meekelenkamp J, Korbeeck JM, Herremans T, Tjhie HT, et al. Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol. 2012;19:1110–5. Wegdam-Blans MCA, Wielders CCH, Meekelenkamp J, Korbeeck JM, Herremans T, Tjhie HT, et al. Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol. 2012;19:1110–5.
40.
go back to reference Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med. 2017;2017:3762651. Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med. 2017;2017:3762651.
41.
go back to reference Edouard S, Raoult D. Lyophilization to improve the sensitivity of qPCR for bacterial DNA detection in serum: the Q fever paradigm. J Med Microbiol. 2016;65:462–7. Edouard S, Raoult D. Lyophilization to improve the sensitivity of qPCR for bacterial DNA detection in serum: the Q fever paradigm. J Med Microbiol. 2016;65:462–7.
Metadata
Title
Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care
Authors
Volker H. Hackert
Nicole H. T. M. Dukers-Muijrers
Christian J. P. A. Hoebe
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05400-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue